Alejandro Luna de Abia

12PUBLICATIONS
107CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 31, 2026
Tumor CD19 Expression Determines Distinct Clinical Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.

|Jan 28, 2026
Apheresis CD8+CCR7+CD45RA- T-Cells as a Novel Biomarker Associated with CAR T-Cell Kinetics and Clinical Outcome.

Iván García de la Torre, Carlota García-Hoz, Fernando Martin-Moro

|Aug 26, 2025
Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma.

Michael Winkelmann, Sandeep S Raj, Michael D Jain

|Aug 15, 2025
Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma.

Xavier Deschênes-Simard, Maria Bromberg, Sean M Devlin

|Apr 14, 2025
CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma.

Alejandro Luna, Sean M Devlin, Kai Rejeski

|Dec 12, 2024
Dynamics of Immune Reconstitution and Impact on Outcomes across CAR-T Cell Products in Large B-cell Lymphoma.

Danny Luan, Susan DeWolf, Teng Fei

Pageof 2

Frequent Collaborators

8 joint publications

Miguel-Angel Perales

7 joint publications

Gilles Salles

7 joint publications

Gunjan L Shah

6 joint publications

Roni Shouval